De patienter, der fik Kepivance, havde væsentligt færre dage (3, 7 dage) med oral mucositis end dem, der fik placebo (10, 4 dage).
The average length of time for which patients had severe oral mucositis was significantly less with Kepivance (3.7 days) than with placebo (10.4 days).